FIELD: pharmacology.
SUBSTANCE: group of inventions relates to tablet for preventing the loss of testosterone, for maintaining physiological levels of androgens, improving sexual function, mood and health, having a weight of 60-120 mg and consisting of: - 60-100 wt % of granules consisting of: 60-85 wt % of dehydroepiandrosterone (DHEA) granules; 6-35 wt % of microcrystalline cellulose granules; 0-20 wt % of granules of one or more pharmaceutically acceptable granule ingredients; and - 0-40 wt % of one or more pharmaceutically acceptable tablet components, as well as to method of preparing the mentioned tablets.
EFFECT: preparation of small tablets with a high content of DHEA, having acceptable release profile.
18 cl, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING TETRAHYDROPHOLIC ACID | 2012 |
|
RU2624236C2 |
| ORALLY DISINTEGRATING TABLET TEMAZEPAM COMPOSITIONS | 2008 |
|
RU2524638C2 |
| COMPOSITION OF BIS-PHOSPHONIC ACIDS FOR WET GRANULATION | 1995 |
|
RU2149003C1 |
| SOLID DOSAGE FORMS OF PALLBOCYCLOB | 2016 |
|
RU2686840C1 |
| ANTIDIABETIC PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 1999 |
|
RU2233659C2 |
| PROLONGED-RELEASE PHARMACEUTICAL COMPOSITION OF ENTACAPONE OR ITS SALTS | 2009 |
|
RU2540465C2 |
| METHOD FOR PREPARING SOLID, ORAL PHARMACEUTICAL FORMULATION | 2009 |
|
RU2493850C2 |
| TAMZULOSIN TABLETS | 2002 |
|
RU2311903C2 |
| METHOD FOR MAKING SOLID ORAL PHARMACEUTICAL COMPOSITION | 2004 |
|
RU2379036C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING TETRAHYDROFOLIC ACID | 2007 |
|
RU2479306C2 |
